Atrial and Ventricular Functional MR: Treatment Implications
9 min.
Innovalve TMVR A new transcatheter mitral valve replacement system
10 min.
M3 Trial (Encircle)
5 min.
Next Generation TMVR Devices: A Step Forward in Patient Selection and Eligibility?
18 min.
Are TMVR Devices Designed to Meet the Tricuspid Needs? – Technological Challenges and Opportunities for Innovation
8 min.
Featured TAVR Innovation: Treatment of Infective Endocarditis (IE) Using Drug-Eluting Transcatheter Valve Replacement (DE - TAVR)
7 min.
Interventional Perspectives and Emerging Therapeutic Options
6 min.
APOLLO Trial (Intrepid)
5 min.
ENCIRCLE Trial (M3)
5 min.
SUMMIT Trial (Tendyne)
5 min.
TMVR Performance in Real World Anatomies: Time to Consider Device Version 2.0?
6 min.
Intrepid – APOLLO MAC Cohort
2 min.
Tendyne – SUMMIT MAC Cohort
3 min.
Transfemoral Sapien in MAC
5 min.
Modular Transcatheter Transseptal “ReValvable” Mitral Valve Replacement (ReValve): FIH Results
5 min.
Outcomes of Mitral Regurgitation Patients Screen Failed for LVOT Obstruction Treated Using Altavalve
6 min.
Transfemoral TMVR: Intermediate-Term Outcomes From the Intrepid Early Feasibility Study
6 min.
Central Wrapping Concept for TMVR (Innovalve): Device Description and Early Clinical Results
5 min.
The Opus VR Valve: A Novel TMVR Tethered to the Ventricular Septum (Opus Medical)
3 min.
Choice of Optimal Transcatheter Treatment for Mitral Insufficiency: 2-Year Real-World Outcomes in the CHOICE MI International Registry
6 min.